Dermatologist concerns rejected: topical mometasone to be available OTC from June

The TGA has rejected safety concerns from dermatologists about rescheduling of topical mometasone and has confirmed it will be made available over the counter in pharmacies from 1 June. In 2019 the Australasian College of Dermatologists strongly opposed an interim decision by the TGA’s Advisory Committee on Medicines Schedule (ACMS) to permit OTC sale of ...

Already a member?

Login to keep reading.

© 2021 the limbic